Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A
Davood Javidgonbadi1, Bert Andersson2, Nils-Johan Abdon3
1Department of Cardiology, Northern Älvsborg County Hospital, Trollhättan, Sweden.
Insights
Short atrio-ventricular delay pacing offers a safe and cost-effective treatment for hypertrophic obstructive cardiomyopathy (HOCM) compared to myectomy, with fewer complications and re-interventions.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) treatment often involves myectomy or pacing.
- Long-term morbidity data comparing these HOCM treatments is limited.
- Short atrio-ventricular delay pacing demonstrates comparable hemodynamic results to myectomy.
Purpose of the Study:
- To compare the long-term morbidity of short atrio-ventricular delay pacing versus myectomy in HOCM patients.
- To evaluate complications, re-interventions, hospital stay, and costs associated with each treatment.
Main Methods:
- Retrospective study of 251 HOCM patients (2002-2013) in West Götaland, Sweden.
- Case-control methodology matched 31 pairs for age, wall thickness, and LVOT-gradient.
- Data collected on peri-procedural and long-term outcomes, including complications and costs.
Main Results:
- Both pacing and myectomy improved NYHA class and LVOT-gradients.
- Pacing had significantly fewer peri-procedural complications (3.2% vs. 35.5%).
- Pacing group showed superior freedom from re-interventions (90.3% vs. 61.3%), shorter hospital stays, and lower costs.
Conclusions:
- Short atrio-ventricular delay pacing is a reliable treatment for drug-refractory HOCM.
- Pacing presents a lower complication rate and reduced healthcare costs compared to myectomy.
- Pacing offers a favorable long-term outcome profile for HOCM management.
Background:
Treatment of left ventricular outflow-obstruction (LVOTO) in hypertrophic obstructive cardiomyopathy (HOCM) by short atrio-ventricular delay pacing has long-term hemodynamic results that are not inferior to myectomy, but publications comparing long-term morbidity following those treatments are lacking.
Methods:
A search for HOCM-patients attending all ten hospitals in the West Götaland Region, Sweden, from 2002 through 2013, identified 251 patients (42 treated with myectomy, 88 with pacing and 121 conservatively). As the age at procedure was significantly lower in the myectomy-group compared to the pacing-group, morbidity was compared by case-control methodology, matching patients for age, maximal wall thickness and LVOT-gradient. We found 31 pairs who constituted the comparison-groups. Post-intervention median follow-up was 15.4 and 10.4 years in pacing- and myectomy-group, respectively. Post-procedural and long-term complications and re-interventions, length of stay, and cost of hospitalization were documented.
Results:
Both treatments improved New York Heart Association class and LVOT-gradients significantly. There were fewer peri-procedural complications in the pacing-group compared to myectomy-group (3.2% and 35.5% p < 0.001). During follow-up pacemaker was implanted in 35.5% of myectomy-group for atrio-ventricular block, 9.7% peri-operatively, and 25.8% during late-follow-up. Furthermore, the pacing group had a superior freedom from all re-interventions, 90.3% versus 61.3% in myectomy-group (p = 0.003). Pacing patients had a shorter in-hospital stay (median 4 [IQR = 2] days) compared to myectomy 11 [7] days; P < 0.001). The mean cost of hospitalization was 74,000 ± 16,000 SEK for pacing and 310,000 ± 180,000 SEK for myectomy, p < 0.001.
Conclusion:
Pacing is a simple and reliable treatment for drug-refractory HOCM-patients with low rate of complications and costs.
More Related Videos
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
